Hasbani Follows Up The Death Of Farah Kassab And Issues Two Decisions And Two Letters To The General

Hasbani Follows up the Death of Farah Kassab and Issues Two Decisions and Two Letters to the General Prosecution and the Order of Physicians

The Information Office of Deputy Prime Minister Health Minister Ghassan Hasbani issued the following statement:

In the context of following up the death of Farah Kassab after she underwent a cosmetic surgery in a specialized hospital in cosmetic surgeries,

Health Minister Ghassan Hasbani took the following actions:

The issuance of a decision on the prevention of surgical operations that require a general anesthetic in day hospitals or other cosmetic surgery clinics.
The issuance of a decision on the prevention of surgical operations that require a general anesthetic in Dr. Nader Saab hospital specialized in cosmetic surgery.
The issuance of a letter to the Public Prosecutor to investigate into the death of Farah Kassab.
The issuance of a letter to the Lebanese Order of Physicians in Beirut to conduct necessary investigations into the death of Farah Kassab, and give the Order a period of two weeks to clarify some technical medical points and answer questions asked by Health Minister concerning the death of the said woman.

These steps came to complete the immediate oral decision of Health Minister Ghassan Hasbani to cease operations in the said clinic after the woman's death, and the written decision issued Friday 2 June 2017 which stipulates the following:

Surgeries that may cause complications that require intensive care like liposuction and other surgeries shall not performed in places other than specialized hospitals which include an intensive care division that holds a license form Health Ministry in accordance with due process.
The doctor should explain to the patient the risks of the surgery, including the plastic surgery, and ask the patient to sign the Patient Right Form and the informed consent.

...

All

ATC	Name	B/G	Ingredients	Form	Price
B05BB01	SERUFLEX LACTATED RINGER'S INJECTION, USP	G	Sodium lactate - 3.1g/l, Calcium chloride, 2H2O - 0.2g/l, Potassium chloride - 0.3g/l, Sodium chloride - 6g/l	Injectable solution	232,134 L.L
B05BB01	SOLUFLEX LACTATED RINGER'S INJECTION, USP	G	Sodium lactate - 3.1g/l, Calcium chloride, 2H2O - 0.2g/l, Potassium chloride - 0.3g/l, Sodium chloride - 6g/l	Injectable solution	264,311 L.L
N02BE51	SICADOL EXTRA	G	Paracetamol - 500mg, Caffeine - 65mg	Tablet	147,823 L.L
N06CA02	SERNIL	G	Flupentixol - 0.5mg, Melitracen - 10mg	Tablet	1,003,402 L.L
C09DB02	SEVIKAR	B	Olmesartan medoxomil - 20mg, Amlodipine - 5mg	Tablet, film coated	1,019,976 L.L
N02BE51	SOLPADEINE	B	Paracetamol - 500mg, Caffeine - 30mg, Codeine - 8mg	Tablet	319,835 L.L
B05BB01	SERUFLEX RINGER'S INJECTION, USP	G	Calcium chloride, 2H2O - 0.33g/l, Potassium chloride - 0.3g/l, Sodium chloride - 8.6g/l	Injectable solution	204,554 L.L
C09DB02	SEVIKAR	B	Olmesartan medoxomil - 40mg, Amlodipine - 5mg	Tablet, film coated	1,158,392 L.L
N02BE51	SOLPADEINE SOLUBLE	B	Paracetamol - 500mg, Caffeine - 30mg, Codeine - 8mg	Tablet, effervescent	326,554 L.L
B05BB01	SOLUFLEX RINGER'S INJECTION, USP	G	Calcium chloride, 2H2O - 0.33g/l, Potassium chloride - 0.3g/l, Sodium chloride - 8.6g/l	Injectable solution	221,792 L.L
N02BE51	SOLPEX	G	Paracetamol - 500mg, Caffeine - 30mg, Codeine - 8mg	Tablet	243,172 L.L
S01EC54	SIMBRINZA	B	Brinzolamide - 1%, Brimonidine tartrate - 0.2%	Drops suspension	1,706,680 L.L
C09DB02	SEVIKAR	B	Olmesartan medoxomil - 40mg, Amlodipine - 10mg	Tablet, film coated	1,245,742 L.L
B05BB02	SERUFLEX DEXTROSE 5% SODIUM CHLORIDE 0.9% INJECTION, USP	G	Sodium chloride - 0.9%, Glucose - 5%	Injectable solution	194,211 L.L
B05BB02	SERUFLEX DEXTROSE 5% SODIUM CHLORIDE 0.9% INJECTION, USP	G	Sodium chloride - 0.9%, Glucose - 5%	Injectable solution	180,421 L.L
B05BB02	SOLUFLEX DEXTROSE 5% SODIUM CHLORIDE 0.9% INJECTION, USP	G	Sodium chloride - 0.9%, Glucose - 5%	Injectable solution	222,941 L.L
B05BB02	SOLUFLEX DEXTROSE 5% SODIUM CHLORIDE 0.9% INJECTION, USP	G	Sodium chloride - 0.9%, Glucose - 5%	Injectable solution	158,587 L.L
A10BD07	SAGIMET	G	Metformin HCl - 1000mg, Sitagliptin (HCl monohydrate) - 50mg	Tablet, film coated	1,551,690 L.L
A10BD07	SITAMET	G	Metformin - 1000mg, Sitagliptin - 50mg	Tablet, film coated	2,541,715 L.L
A10BD07	SITAVITEA PLUS	G	Metformin - 1000mg, Sitagliptin - 50mg	Tablet, film coated	1,079,106 L.L
B05BB02	SERUFLEX DEXTROSE 5% SODIUM CHLORIDE 0.45% INJECTION, USP	G	Sodium chloride - 0.45%, Glucose - 5%	Injectable solution	193,062 L.L
B05BB02	SERUFLEX DEXTROSE 5% SODIUM CHLORIDE 0.45% INJECTION, USP	G	Sodium chloride - 0.45%, Glucose - 5%	Injectable solution	180,421 L.L
B05BB02	SOLUFLEX DEXTROSE 5% SODIUM CHLORIDE 0.45% INJECTION, USP	G	Sodium chloride - 0.45%, Glucose - 5%	Injectable solution	236,731 L.L
A10BD07	SAGIMET	G	Metformin HCl - 500mg, Sitagliptin (HCl monohydrate) - 50mg	Tablet, film coated	1,432,536 L.L
B05BB02	SOLUFLEX DEXTROSE 5% SODIUM CHLORIDE 0.45% INJECTION, USP	G	Sodium chloride - 0.45%, Glucose - 5%	Injectable solution	211,449 L.L
R05C	SULDEX	G	Caffein anyhdrous - 0.216g, Antipyrine - 0.972g, Potassium sulfaguaiacolate - 1.44g	Syrup	152,302 L.L
A10BD07	SAGIMET	G	Metformin HCl - 850mg, Sitagliptin (HCl monohydrate) - 50mg	Tablet, film coated	1,463,892 L.L
A10BD07	SITAMET	G	Metformin - 850mg, Sitagliptin - 50mg	Tablet, film coated	2,392,203 L.L
A10BD07	SITAVITEA PLUS	G	Metformin - 850mg, Sitagliptin - 50mg	Tablet, film coated	1,079,106 L.L
N07BC51	SUBOXONE	G	Buprenorphine HCl - 2mg, Naloxone HCl - 0.5mg	Tablet, sublingual	1,473,590 L.L

...